Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae in Thailand

Infection Control and Hospital Epidemiology

Volumn 28, Issue 7, 2007, Pages 873-876

  Apisarnthanarak, Anucha ^a   Kiratisin, Pattarachai ^b   Saifon, Payawan ^b   Kitphati, Rungrueng ^c   Dejsirilert, Surang ^c   Mundy, Linda M ^d  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Thai National Institute of Health   (Thailand)

^d SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEPHALOSPORIN DERIVATIVE;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CONTROLLED STUDY; ENTEROBACTER INFECTION; ESCHERICHIA COLI; FEMALE; HUMAN; INFECTION; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RISK FACTOR; THAILAND;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CASE-CONTROL STUDIES; CROSS INFECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; RISK FACTORS; THAILAND;

EID: 34447343359     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/518725     Document Type: Article

References (10)

1. Meyer KS, Urban C, Eagen JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119:353-358.
2. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001; 32:1162-1171.
3. Paterson DL, Ko WC, Von Gottberg A, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 2004; 140:26-32.
4. Hyle EP, Lipworth AD, Zaoutis TE, et al. Risk factors for increasing multidrug resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 2005; 40: 1317-1324.
5. Kang CI, Kim SH, Kim DM, et al. Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2004; 25:860-867.
6. Lin MF, Huang ML, Lai SH. Risk factors in the acquisition of extended-spectrum beta-lactamase Klebsiella pneumoniae: a case-control study in a district teaching hospital in Taiwan. J Hosp Infect 2003; 53:39-45.
7. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-140.
8. Clinincal and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing: 16th Informational Supplement. Wayne, PA: CLSI; 2006:M100-S16.
9. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis 2000; 31(suppl 4):S131-S138.
10. Harris AD, Karchmer TB, Carmeli Y, Samore MH. Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. Clin Infect Dis 2001; 32:1055-1061.